Target intelligence / Profile preview

TRK family, Ephrin family, and RET proto-oncogene kinases

Molecular classification: Multiple receptor tyrosine kinase families

Overview

The query improperly combines multiple unrelated receptor tyrosine kinase families. Each family (TRK, Eph, RET) is independently classified, and "TRK family, Ephrin family, and RET proto-oncogene kinases" should not be grouped as a single canonical target. For structured annotation, each must be treated separately for specificity and scientific accuracy.

Beyond the preview

Go deeper on TRK family, Ephrin family, and RET proto-oncogene kinases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRK family, Ephrin family, and RET proto-oncogene kinases.

Explore the full profile